Literature DB >> 8209786

Regulation of platelet function by the cytoskeleton.

J E Fox1.   

Abstract

The platelet cytoskeleton contains two actin filament-based components. One is the cytoplasmic actin filaments that fill the cytoplasm and mediate contractile events. The other is the membrane skeleton that coats the plasma membrane and regulates properties of the membrane such as its contours and stability and the lateral distribution of membrane glycoproteins. Recent work reviewed in this article indicates that the GP IIb-IIIa complex can associate with the membrane skeleton. Upon platelet activation, GP IIb-IIIa becomes competent to bind its adhesive ligand, fibrinogen. This induces a reorganization of the cytoskeleton such that the membrane skeletal proteins with which GP IIb-IIIa is associated become associated with underlying cytoplasmic filaments. As in focal contacts of cultured cells, this ligand-induced association of GP IIb-IIIa with cytoplasmic actin filaments regulates the ability of GP IIb-IIIa to bind adhesive ligand. Intracellular enzymes that are activated as a consequence of ligand binding to the GP IIb-IIIa complex include tyrosine kinase(s) and calpain, making these potential candidates for enzymes inducing the two-way signaling across the membrane. Additional candidates include phosphoinositide 3-kinase and protein kinase C, other enzymes that have been detected in focal contacts of aggregating platelets. Future studies identifying interactions between the GP IIb-IIIa complex and membrane skeletal proteins should help to further elucidate the significance of the GP IIb-IIIa in cytoskeleton interaction in regulating integrin-mediated transmembrane signaling in platelets.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8209786     DOI: 10.1007/978-1-4615-2994-1_13

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  9 in total

1.  Phosphoinositide 3-kinase p110 beta regulates integrin alpha IIb beta 3 avidity and the cellular transmission of contractile forces.

Authors:  Simone M Schoenwaelder; Akiko Ono; Warwick S Nesbitt; Joanna Lim; Kate Jarman; Shaun P Jackson
Journal:  J Biol Chem       Date:  2009-11-23       Impact factor: 5.157

2.  Differential phosphorylation of myosin light chain (Thr)18 and (Ser)19 and functional implications in platelets.

Authors:  T M Getz; C A Dangelmaier; J Jin; J L Daniel; S P Kunapuli
Journal:  J Thromb Haemost       Date:  2010-10       Impact factor: 5.824

3.  Regulation of LIM-kinase 1 and cofilin in thrombin-stimulated platelets.

Authors:  Dharmendra Pandey; Pankaj Goyal; James R Bamburg; Wolfgang Siess
Journal:  Blood       Date:  2005-10-11       Impact factor: 22.113

4.  Cytoskeletal domains in the activated platelet.

Authors:  E L Bearer
Journal:  Cell Motil Cytoskeleton       Date:  1995

5.  Exposure of ligand-binding sites on platelet integrin alpha IIB/beta 3 by phosphorylation of the beta 3 subunit.

Authors:  G van Willigen; I Hers; G Gorter; J W Akkerman
Journal:  Biochem J       Date:  1996-03-15       Impact factor: 3.857

6.  Gene targeting implicates Cdc42 GTPase in GPVI and non-GPVI mediated platelet filopodia formation, secretion and aggregation.

Authors:  Huzoor Akbar; Xun Shang; Rehana Perveen; Mark Berryman; Kevin Funk; James F Johnson; Narendra N Tandon; Yi Zheng
Journal:  PLoS One       Date:  2011-07-18       Impact factor: 3.240

7.  Cofilin oligomer formation occurs in vivo and is regulated by cofilin phosphorylation.

Authors:  Pankaj Goyal; Dharmendra Pandey; Daniela Brünnert; Elke Hammer; Marek Zygmunt; Wolfgang Siess
Journal:  PLoS One       Date:  2013-08-08       Impact factor: 3.240

8.  Mlck1a is expressed in zebrafish thrombocytes and is an essential component of thrombus formation.

Authors:  E Tournoij; G J Weber; J W N Akkerman; P G de Groot; L I Zon; F L Moll; S Schulte-Merker
Journal:  J Thromb Haemost       Date:  2009-12-11       Impact factor: 5.824

9.  The proline-rich focal adhesion and microfilament protein VASP is a ligand for profilins.

Authors:  M Reinhard; K Giehl; K Abel; C Haffner; T Jarchau; V Hoppe; B M Jockusch; U Walter
Journal:  EMBO J       Date:  1995-04-18       Impact factor: 11.598

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.